✦ LIBER ✦

An engineered human antibody to TNF (CDP571) for active crohn's disease: A randomized double-blind placebo-controlled trial

✍ Scribed by William J. Sandborn; Brian G. Feagan; Stephen B. Hanauer; Daniel H. Present; Lloyd R. Sutherland; Michael A. Kamm; Douglas C. Wolf; Jeffrey P. Baker; Christopher Hawkey; Andre Archambault; Charles N. Bernstein; Claire Novak; Patricia K. Heath; Stephen R. Targan

Book ID: 119756224
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 160 KB
Volume: 120
Category: Article
ISSN: 0016-5085
DOI: 10.1053/gast.2001.24042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Etanercept for Active Crohn's Disease: A

Etanercept for Active Crohn's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial

✍ William J. Sandborn; Stephen B. Hanauer; Seymour Katz; Michael Safdi; Douglas G. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 181 KB

A randomized, placebo-controlled trial o

A randomized, placebo-controlled trial of CDP571, a humanized monoclonal antibody to TNF-α, in patients with moderate to severe Crohn's disease

✍ William J. Sandborn; Brian Feagan; Graham Radford-Smith; Agota Kovacs; Robert En 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 168 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of olsalazine for active Crohn's disease

✍ J. P. Wright; Dr. D. P. Jewell; R. Modigliani; H. Malchow 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB 👁 2 views

Olsalazine, consisting of two salicylate radicals linked by an azo-bond, is effective in the treatment of active ulcerative colitis. To test its effect in patients with mild to moderate attacks of Crohn's disease, the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) des

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-α, in patients with corticosteroid-dependent Crohn's disease

✍ B. G. Feagan; W. J. Sandborn; J. P. Baker; F. Cominelli; L. R. Sutherland; C. O 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB

A randomized controlled trial of CDP571,

A randomized controlled trial of CDP571, a humanized antibody to TNFA, in moderately to severely active Crohn's disease

✍ Sanborn, William J.; Targan, Stephan R.; Hanauer, Stephan B.; Present, Daniel H. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 165 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled, multi-center trial of the engineered human anti body to TNF (CDP571) for steroid sparing and maintenance of remission in patients with steroid-dependent Crohn's disease

✍ Feagan, Brian G.; Sandborn, William J.; Baker, J.P.; Cominelli, F.; Sutherland, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 165 KB